HBM Healthcare Investments AG (HBMN.SW) stock: Winston Score, insiders and Congress trades

HBM Healthcare Investments AG is a Swiss investment company that puts money into healthcare and biotech businesses around the world. It buys stakes in private and publicly traded companies working on drugs, medical devices, and other health-related products. Think of it like a fund that specializes entirely in the healthcare industry, giving investors a way to own a slice of many healthcare companies at once. The company makes money when the value of its investments rises and when it sells stakes at a profit — not from selling products or charging fees to customers. It is based in Zug, Switzerland, and invests mainly in companies across the US, Europe, and Asia, with a portfolio worth roughly $1.5 billion. Its focus on a single sector gives it deep expertise, but that same concentration is also its biggest risk — a broad downturn in biotech valuations or a string of failed drug trials across its portfolio could significantly hurt returns.

Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-11.